BETHESDA, Md., April 30, 2026 /PRNewswire/ — Northwest Biotherapeutics, Inc. (OTCQB:NWBO) (the “Company” or “NWBio”), a biotechnology company developing DCVax personalized immune therapies for so…
Northwest Biotherapeutics, Inc.: Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform
Source: Finanznachrichten.de
Read Full Story →
